Company / Total Debt
Harmony Biosciences Holdings, Inc. Total Debt History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$163.7M
FY2025
5-year range
$163.7M / $193.6M
FY2021-FY2025
Trend
-8.7%
vs FY2024
Sector context
#48 of 83
Health Care
What the data says
At $164M, Harmony Biosciences Holdings, Inc.'s total debt ranks #36 of 83 in the Health Care sector. Total Debt has fluctuated over the past 7 years, ranging from $98M in FY2019 to $194M in FY2020.
Based on SEC 10-K filings.
$164M in FY2025 with a 5-year CAGR of -3.4%.
Improved from $194M to $164M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#36 of 83 in Health CareTop 42% of 83This company $163.7M Sector average $6.2B
▼
-97.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, total debt decreased 8.7% year-over-year.
- Ranks #48 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $163.7M | -8.7% |
| FY2024 | $179.3M | -7.4% |
| FY2023 | $193.6M | +1.0% |
| FY2022 | $191.6M | +0.9% |
| FY2021 | $190.0M | -2.2% |
| FY2020 | $194.3M | +98.3% |
| FY2019 | $97.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026